Aristotle University Of Thessaloniki (AUTH)
Ενέσιμες υδροπηκτές με βάση το υαλουρονικό οξύ για επιδιόρθωση του αρθρικού χόνδρου
Abstract
dc:descriptionThe purpose of this thesis is to develop injectable hydrogels based on hyaluronic acid, a natural polymer found in the human body, for the repair of cartilage lesions. The existing procedures for the repair of cartilage lesions are invasive and have limitations with respect to geometry and cartilage defect size. Therefore, there is a great need for the development of non-invasive treatments for the repair of small cartilage injuries. In this context, the development of injectable methacrylated hyaluronic acid (MeHA) hydrogels, synthesized using two different crosslinking methods, has been effected. In particular, a redox initiation system of ammonium persulfate (APS) and N,N,N,N΄- tetramethylenediamine (TEMED), and a matrix metalloproteinase 7 (MMP7)-sensitive peptide were effectively used for the formation of MeHA based hydrogels. During this study, the influence of the molecular weight of HA, degree of methacrylation (DM), and biofunctionalization of MeHA using a chondroitin sulfate (CS) binding peptide, was experimentally assessed. Concerning the use of the MMP7-degradable peptide as crosslinker, it was observed that, as the concentration of the peptide crosslinker increased, the gelation onset time and the degradation rate of the synthesized hydrogels were decreased, while their storage modulus (G′) increased. The use of CS-MeHA as a functional macromer resulted in a retardation of the gelation onset and the formation of softer hydrogels. Finally, the crosslinking reaction in cell growth medium was shown to increase the G’ of the formed hydrogel to values that could favor the differentiation of human mesenchymal stem cells (hMSCs) to chondrocytes. The successful development of injectable MeHA hydrogels using an MMP7-degradable peptide as crosslinker was followed by their embedding with a low concentration of either human mesenchymal stem cells (hMSCs) or chondrocytes. hMSC-laden MeHA and CS-MeHA hydrogels were cultured either in stem cell medium (SCM) or chondrogenic medium (CiM), and assessed regarding their ability to promote the differentiation of hMSCs towards a chondrogenic and/or hypertrophic phenotype, as well as to maintain the viability of the encapsulated cells. The developed MeHA and CS-MeHA hydrogels appeared to provide a proper environment for the growth and proliferation of hMSCs. This was enhanced in the case of CS-MeHA hydrogels showing the positive effect of the chondroitin sulfate binding peptide on the chondrogenic differentiation of hMSCs. However, the use of chondrogenic medium was considered necessary in order to obtain full-span chondrogenesis. Finally, the chondrocyte-laden MeHA hydrogels were cultured in an ex vivo osteochondral platform and assessed regarding their ability to form cartilage extracellular matrix. Distribution of glycosaminoglycans and development of chondrocyte clusters in isogenous groups, characteristic of hyaline cartilage morphology, were observed on the fourteenth day of the ex vivo culture.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2020
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Tsanaktsidou, Evgenia
- Τσανακτσίδου, Ευγενία
Subjects
dc:subject × 14- Ενέσιμες υδροπηκτές
- Αρθρικός χόνδρος
- Ανθρώπινα μεσεγχυματικά βλαστικά κύτταρα
- Χονδροκύτταρα
- Πεπτίδια
- Injectable hydrogels
- Articular cartilage
- Human mesenchymal stem cells
- Chondrocytes
- Peptides
- Επιστήμες Μηχανικού και Τεχνολογία
- Άλλες Επιστήμες Μηχανικού και Τεχνολογίες
- Engineering and Technology
- Other Engineering and Technologies
Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/48454